DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Misonidazole is an investigational drug.
There have been 13 clinical trials for Misonidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Glioblastoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and AstraZeneca.
Recent Clinical Trials for Misonidazole
|Feasibility of FMISO in Brain Tumors||National Cancer Institute (NCI)||Phase 2|
|Feasibility of FMISO in Brain Tumors||OHSU Knight Cancer Institute||Phase 2|
|Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment||Abramson Cancer Center of the University of Pennsylvania||Phase 1|